NEIL MENDONCA: Open Payments
NPI 1306513916 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 4 payments from 4 companies in 2025. Trend: 2023 $838 · 2024 $1,368 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
Products named: INGREZZA, FANAPT, ABILIFY MAINTENA, UZEDY.
Industry payments across PA — which companies pay providers there.
